H. Ikushima

Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.

S. Iwata, C. Morimoto, K. Ohnuma, 2002, Cellular immunology.

The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis.

T. Hirano, S. Hirota, Y. Kitamura, 2004, International immunology.

Cutting Edge: Requirement for Growth Hormone-Releasing Hormone in the Development of Experimental Autoimmune Encephalomyelitis 1

M. Kanaoka, Shinich Kojima, H. Ikushima, 2003, The Journal of Immunology.

Development of Experimental Autoimmune Hormone-Releasing Hormone in the Cutting Edge: Requirement for Growth

H. Ikushima, 2003 .

Internalization of CD 26 by mannose 6-phosphate y insulin-like growth factor II receptor contributes to T cell activation

S. Iwata, C. Morimoto, Hirotoshi Tanaka, 2000 .

A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis

Y. Saeki, T. Hirano, S. Hirota, 2002, The Journal of experimental medicine.

Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation.

S. Iwata, C. Morimoto, T. Ishii, 2000, Proceedings of the National Academy of Sciences of the United States of America.

CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.

S. Iwata, C. Morimoto, S. Schlossman, 1999, International immunology.

Different Regulatory Effects of Pentoxifylline on Human T Cell Activation Pathways

C. Morimoto, S. Schlossman, Y. Umezawa, 1997, Journal of Clinical Immunology.